adverse reactions
ADVERSE REACTIONS Rash with generalized erythema, facial edema and fever has been reported in less than 1% of patients. A transient increase in blood pressure was seen in 8% of patients.
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
| Harmonized routes |
|---|
| INTRAVENOUS |
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 019829 | derived:openfda.application_number |
| application number | NDA019829 | openfda.application_number | |
| brand name | CERETEC | openfda.brand_name | |
| generic name | TECHNETIUM TC-99M EXAMETAZIME | openfda.generic_name | |
| manufacturer name | Medi-Physics Inc. dba GE Healthcare. | openfda.manufacturer_name | |
| ndc | package | 17156-022-05 | openfda.package_ndc |
| ndc | product | 17156-022 | openfda.product_ndc |
| ndc11 | package | 17156002205 | derived:openfda.package_ndc |
| spl id | 87cca989-b750-4ca7-9b5a-6f00d0457c46 | id | |
| spl set id | 3c1eca7e-57a0-4876-8ed6-cd655ef5e296 | set_id | |
| unii | 3B744AG22N | openfda.unii |
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse event summaries are temporarily unavailable. Other product information remains available.